» Articles » PMID: 33014057

Minocycline in Treating Glioblastoma Multiforme: Far Beyond a Conventional Antibiotic

Overview
Journal J Oncol
Specialty Oncology
Date 2020 Oct 5
PMID 33014057
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

One of the most lethal forms of CNS pathologies is glioblastoma multiforme (GBM) that represents high invasiveness, uncontrolled proliferation, and angiogenic features. Its invasiveness is responsible for the high recurrence even after maximal surgical interventions. Minocycline is a semisynthetic analog of tetracyclines with potential anti-inflammatory and anticancer effects, distinct from its antimicrobial activity. In this review, we highlight the importance and the cytotoxic mechanisms of minocycline on GBM pathophysiology. Considering the role of certain enzymes in autophagy, apoptosis, tumor cell invasion, and metastatic ability, the possible use of tetracyclines for cancer therapy should be investigated, especially GBM. The present study is, therefore, going to cover the main topics in minocycline pharmacology to date, encouraging its consideration as a new treatment approach for cancer and GBM.

Citing Articles

Reversal gene expression assessment for drug repurposing, a case study of glioblastoma.

Sun S, Shyr Z, McDaniel K, Fang Y, Tao D, Chen C J Transl Med. 2025; 23(1):25.

PMID: 39773231 PMC: 11706105. DOI: 10.1186/s12967-024-06046-1.


Drug Repurposing for Cancer Treatment: A Comprehensive Review.

Al Khzem A, Gomaa M, Alturki M, Tawfeeq N, Sarafroz M, Alonaizi S Int J Mol Sci. 2024; 25(22).

PMID: 39596504 PMC: 11595001. DOI: 10.3390/ijms252212441.


Reversal Gene Expression Assessment for Drug Repurposing, a Case Study of Glioblastoma.

Sun S, Shyr Z, McDaniel K, Fang Y, Tao D, Chen C Res Sq. 2024; .

PMID: 39315277 PMC: 11419258. DOI: 10.21203/rs.3.rs-4765282/v1.


Novel Collagen Membrane Formulations with Irinotecan or Minocycline for Potential Application in Brain Cancer.

Idu A, Albu Kaya M, Rau I, Radu N, Dinu-Pirvu C, Ghica M Materials (Basel). 2024; 17(14).

PMID: 39063802 PMC: 11278765. DOI: 10.3390/ma17143510.


Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential.

Nusraty S, Boddeti U, Zaghloul K, Brown D Cancers (Basel). 2024; 16(11).

PMID: 38893093 PMC: 11171200. DOI: 10.3390/cancers16111972.


References
1.
Cao Z, Liao Q, Su M, Huang K, Jin J, Cao D . AKT and ERK dual inhibitors: The way forward?. Cancer Lett. 2019; 459:30-40. DOI: 10.1016/j.canlet.2019.05.025. View

2.
Higashi Y, Mummidi S, Sukhanov S, Yoshida T, Noda M, Delafontaine P . Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression. Cell Signal. 2019; 57:10-20. PMC: 6732797. DOI: 10.1016/j.cellsig.2019.01.014. View

3.
Garrido-Mesa N, Camuesco D, Arribas B, Comalada M, Bailon E, Cueto-Sola M . The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties. Pharmacol Res. 2011; 63(4):308-19. DOI: 10.1016/j.phrs.2010.12.011. View

4.
Hirota K, Semenza G . Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 2006; 59(1):15-26. DOI: 10.1016/j.critrevonc.2005.12.003. View

5.
Das B, Thapa P, Karki R, Das S, Mahapatra S, Liu T . Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014; 22(2):673-83. PMC: 4447240. DOI: 10.1016/j.bmc.2013.11.025. View